Personalized Health Basel (PHB) aims to develop and promote Personalized Health for the benefit of patients, research and society.
By harmonizing existing processes, building new information technology (IT) and biobanking infrastructures, and by forming national and international research collaborations we will consolidate the Basel area as a hub of research excellence and a place where people benefit from personalized healthcare.
Our activities are closely coordinated with our partners in Zurich within the Personalized Health Alliance Zurich-Basel. Our goal is to participate in initiatives of the Swiss Personalized Health Network (SPHN).
The 2018 Award aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine. Individuals who have published scientific papers and/or developed best practice strategies in the field of PM between January 1st, 2016 and December 31st, 2017, from any of the ICPerMed partner countries, are eligible to apply.
Submission deadline for applications: March 2nd, 2018
Date and Time: 28 February 2018, 18:40 - 21:00
Place: Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel
Free Registration on the website
"On this DayOne Experts Event, leaders from the Swiss Personalized Health Network (SPHN) will give first hand insights into the initiative and researchers will present their projects. The panel discussion with industry experts will focus on the goals, challenges and opportunities of the SPHN initiative. If you want to find out more about Switzerland’s efforts in facilitating research projects in the area of personalized health and precision medicine, please join us at this DayOne Experts Event."
Date: Thursday, 1 March, 2018
Room: Hörsaal 2, Pharmazentrum, Klingelbergstrasse 70, Basel
Precision medicine is around the corner, fueled notably by the immense progress achieved on the front of genome sequencing. This is clearly a desirable evolution, but the security and privacy implications absolutely need tackling.
In this talk, we will mention the numerous threats induced by precision medicine in general (including the “quantified self”) and by genomics in particular. We will discuss possible IT architectures for genomic (and phenotypic) data generation, processing, and protection, and present the solutions envisioned by the (few) researchers working on the topic.
We will address the benefits and limitations of using homomorphic encryption for the protection of genomic data. We will detail the system we are currently developing for the privacy-conscious sharing of data between Swiss hospitals. Finally, we will address the problem of inference attacks against genome databases and discuss the implications for kinship.
We will also present the recently approved 3-years EPFL-ETH project titled Data Protection for Personalized Health. This project is part of the SPHN/PHRT program.
The community Web site we have set up on the topic of genome privacy and security can be found at https://genomeprivacy.org
This Certificate of Advanced Studies (CAS) is organized jointly by the University Hospital of Basel, the University Hospital of Lausanne, and the SIB Swiss Institute of Bioinformatics.
For information and applications visit the website
Cutting-edge technologies, like next-generation-sequencing (NGS), combined with the development of targeted therapies are now revolutionizing clinical practice, bringing new complexity to the field of oncology. The CAS in Personalized Molecular Oncology aims at providing a comprehensive and integrative view of the field, by covering all the aspects involved along the pipeline: (i) tumor biology and genetics, (ii) molecular pathology, (iii) clinical bioinformatics, and (iv) clinical oncology.
First of its kind in Switzerland, it will focus on the methodologies used to generate, analyze and interpret patients’ molecular profiles, also touching upon the associated technical, regulatory and ethical challenges. As an important outcome, it will establish a common language between the wide range of professionals involved in the personalized oncology process, from biologists, bioinformaticians, pathologists to clinicians, enabling an efficient and better informed use of e.g. genomic data for both routine clinical practice and clinical research. Moreover, it should empower professionals to develop a vision for their own institution, by critically evaluating the potential benefits and limitations of current and future developments in personalized oncology.
NEXUS Personalized Health Technologies and the Competence Center Personalized Medicine UZH/ETH (part of the PH Alliance Zurich-Basel) are looking forward to welcoming researchers, clinicians and scientists from university, industry and the public sector who are interested in the latest progress of personalized health technologies, translational research and development.
For more information visit the conference website
A flourishing research hub needs adequate infrastructure at its foundation. PHB has defined four areas to be further developed: Clincal Data Warehouse, Biobanking, Clinical Bioinformatics, and Ethical – Legal – Societal Implications (ELSI). To ensure the infrastructure follows the needs of the science, the three research focus areas "Oncology", "Immunology", and "Infectious Diseases" will run first projects on the new platform. At the same time we work on interoperability in the same infrastructure and research focus areas with our partners of the PH-Alliance Zurich-Basel. For nation-wide data sharing and research we participate in the Swiss Personalized Health Network (SPHN).
Prof. Radek Skoda
Prof. Mirjam Christ-Crain
Prof. Christiane Pauli-Magnus
Prof. Urs Frey
Personalized Health Manager:
Coordinator PHB Research Clusters:
Dr. Thomas Geiger
Dr. Cristina Golfieri
Head Department of Clinical Research
Head Department of Clinical Research / Head Clinical Trial Unit
Clinical Director University Children’s Hospital Basel
Personalized Health Manager
Coordinator PHB Research Clusters
Personalized Health Manager